DELCF News and Press, Delic Holdings From 07/29/22

DELIC COMPLETES OFFERING OF DEBENTURES Canada NewsWire VANCOUVER, BC , July 29, 2022 /CNW/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is plea...

The United States Drug Enforcement Administration (DEA) has been sued again for refusing to permit a doctor to treat patients with terminal illnesses using psilocybin therapy in accordance with state and federal Right To Try laws. Numerous trials have found that psilocybin, as well as MD...

Last month, Netflix released the trailer for a docuseries called “How to Change Your Mind ,” which was adapted from Michael Pollan’s book on the science of psychedelics and what it could teach us about depression, addiction, dying, consciousness and transcendence. Bas...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which ...

Delic 2021 Revenue Shows Strong Growth as Nation's Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services Canada NewsWire Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO ® to Minneap...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) , a leader in new medicines and treatments for a modern world, today announced that Dr. Markus Roggen, president and chief science officer for Delic Labs, was named to the Cannabis Scientist Power List for the third consecutive year. Due ...

Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year Canada NewsWire The Cannabis Scientist Power List is an annual recognition of the most important innovators within the cannabis industry VANCOUVER...

More than a year ago, a Seattle doctor and several cancer patients sued the U.S. Drug Enforcement Administration after the federal agency sent a letter declaring that the patients could not access synthetic psilocybin under federal and state right-to-try laws . These legislations grant pa...

Interest in psychedelics has grown significantly as mainstream acceptance grows and research uncovers more of the benefits that these substances possess, including how they can be used to manage a range of mental health disorders. These positive advancements have even led some states to de...

There has been increased interest in psychedelic treatments in recent years as initial studies have revealed that psychedelic drugs have the potential to alleviate certain mental health conditions. Psychedelic therapy is a relatively new field, but it has shown great promise in treating co...